Moreover, CCL2 overexpression was shown to be associated with poor prognosis of lung cancer [31], esophageal cancer [32], hepatocellular carcinoma [33], glioblastoma multiforme [34], and diffuse large B-cell lymphoma [35]. Here, CCL2 is linked to diffuse large B-cell lymphoma.